Adipose-derived stromal vascular fraction (SVF) cells for the treatment of non-reconstructable peripheral vascular disease in patients with critical limb ischemia: A 6-year follow-up showing durable effects
We previously reported 18-month results post-injection of adipose-derived stromal vascular fraction (SVF) cells in 10 patients with end-stage peripheral vascular disease (PVD) in critical limb ischemia (CLI) and candidates for amputation, secondary to long-standing diabetes and/or arteriosclerotic d...
Main Authors: | Michael H. Carstens, Maria Zelaya, Dorian Calero, Carlos Rivera, Diego Correa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Stem Cell Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S187350612030372X |
Similar Items
-
Cartilage lesion size and number of stromal vascular fraction (SVF) cells strongly influenced the SVF implantation outcomes in patients with knee osteoarthritis
by: Yong Sang Kim, et al.
Published: (2023-01-01) -
Adipose derived Stromal Vascular Fraction (SVF) cells in the treatment of rheumatoid arthritis of the hand: a 2-year follow-up study
by: M. Carstens, et al.
Published: (2019-04-01) -
Autologous Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF) for Knee Osteoarthritis
by: İbrahim Vargel, et al.
Published: (2022-11-01) -
In vitro cytotoxicity evaluation of flowable hyaluronic acid–acellular stromal vascular fraction (HA–aSVF) mixture for tissue engineering applications
by: Sunil Paramel Mohan, et al.
Published: (2023-01-01) -
Innovative method of alopecia treatment by autologous adipose-derived SVF
by: Sun Jong Kim, et al.
Published: (2021-08-01)